Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Glaukos Corporation
To evaluate the long -term rate of clinically relevant complications associated with iStent inject® placement and stability in subjects who have completed participation of the IDE clinical trial (GC-008).
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Randomized subject followed for 24 months in the GC-008 study
Able to understand study requirements
Willing to attend scheduled follow-up exams for 5 years post-operatively
Able and willing to provide written informed consent on the IRB approved Informed Consent Form
You may not be if
None
Clareo Health | iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study
